Kora Przybyszewska, PhD

Kora Przybyszewska, PhD, has a diverse work experience spanning various roles in the scientific and research field. Kora most recently worked as a Business Development Associate at Fios Genomics, where they specialized in the analysis and integration of multi-variant datasets for drug discovery and development, diagnostics, and agricultural research. Prior to this, Kora worked at Cytochroma, where they held positions as a Scientific Manager, Cell Culture and Production Manager, and Lead Scientist. Their responsibilities included managing scientific projects, overseeing cell culture and production activities, and leading research initiatives. Kora also has experience as a Senior Research Scientist and Molecular & Cellular Biologist at the University of Aberdeen, a Molecular Biologist and Laboratory Technician at Queen's University Belfast, and a Research Scientist, Molecular Microbiologist, and Communication Scientist at Queen's University Belfast. Kora has also had research development internships at Institut Pasteur and Lund University, where they focused on fluorescent microscopy, confocal microscopy, biofilms, antibiotic resistance, and natural antimicrobial peptides. Additionally, they have customer service and graphic design experience from their role as a Customer Service Representative and Graphic Designer at NANDU - Ksero, Druk, Art. Biurowe, Kubki z nadrukiem i inne. Kora's research expertise and diverse work history highlight their strong background in molecular biology, microbiology, and scientific communication.

Kora Przybyszewska, PhD obtained their Doctor of Philosophy (Ph.D.) degree in Medicine, specializing in Molecular Microbiology, from Queen's University Belfast. Kora pursued their Ph.D. education from 2013 to 2017. Prior to that, they completed their Master's degree in Biology/Biological Sciences, General, from Jagiellonian University, where they studied from 2006 to 2011.

In addition to their degrees, Kora Przybyszewska has also obtained several certifications. Kora completed "Introduction to Good Clinical Practice (GCP)" from NIHR (National Institute for Health Research) in April 2019. In March 2017, they acquired "Introduction to GCP for IMP Management (Pharmacy)" from the National Institute for Health Research (NIHR). Furthermore, they have been certified in "PRINCE2® Foundation Certification" from AXELOS Global Best Practice since February 2023.